Matsumoto Oil & Fat Pharmaceutical’s FY2026 financial results show revenue of approximately 590 million yen and net profit of approximately 1.92 million yen. Share buyback and shareholder composition are also disclosed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4365","jir_company_name":"Matsumoto Oil & Fat Pharmaceutical Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-05-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/4365-20260527-01.pdf","jir_short_summary":"Matsumoto Oil & Fat Pharmaceutical's FY2026 financial results show revenue of approximately 590 million yen and net profit of approximately 1.92 million yen. Share buyback and shareholder composition are also disclosed.","jir_summary":"### Performance Overview\nMatsumoto Oil & Fat Pharmaceutical's FY2026 financial results show revenue of approximately 590 million yen and net profit of approximately 1.92 million yen. Revenue compared to the previous year is unknown, but operating income was 97,686 thousand yen, and ordinary income was 219,553 thousand yen, indicating steady performance. The financial position includes total assets of 1.719 billion yen, and it holds 94,500 shares of treasury stock.\n\n### Shareholder Composition and Future Outlook\nThe major shareholder is MK Holdings, which owns 100%. The management team includes President and CEO Naoki Kimura among four members. The company's financial foundation is stable, and future efforts are expected to focus on steady business operations and shareholder returns.","jir_financial_highlights":"Revenue: 5,932,457\u5343\u5186 (unknown)\nNet income for the current term: 191,911\u5343\u5186 (unknown)\nNumber of treasury shares: 94,500 shares (unknown)","jir_category":"","jir_hashtags":"#MatsumotoOilFatPharmaceutical, #IR, #JapanStocks","jir_key_figures":"Revenue: 5,932,457 thousand yen\nNet income: 191,911 thousand yen\nNumber of treasury shares: 94,500 shares","jir_meta_title":"\u3010Matsumoto Oil & Fat Pharmaceutical\u30112026 Financial Results | Revenue approximately 590 million yen \/ Net profit approximately 1.92 million yen","jir_meta_description":"An overview of Matsumoto Oil & Fat Pharmaceutical's FY2026 financial results. Includes revenue of approximately 590 million yen, net profit of approximately 1.92 million yen, as well as financial condition and shareholder composition.","jir_og_title":"\u3010Matsumoto Oil & Fat Pharmaceutical\u30112026 Financial Results | Revenue approximately 590 million yen \/ Net profit approximately 1.92 million yen","jir_og_description":" Detailed explanation of Matsumoto Oil & Fat Pharmaceutical's FY2026 financial results. Summarizes key information such as revenue, net profit, and shareholder structure.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16709,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-54995","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n